Suppr超能文献

尿毒症贫血中红细胞阳离子转运:钾/氯协同转运活性增加的证据。透析和促红细胞生成素治疗的影响。

Red blood cell cation transports in uraemic anaemia: evidence for an increased K/Cl co-transport activity. Effects of dialysis and erythropoietin treatment.

作者信息

De Franceschi L, Olivieri O, Girelli D, Lupo A, Bernich P, Corrocher R

机构信息

Department of Internal Medicine, University of Verona, Italy.

出版信息

Eur J Clin Invest. 1995 Oct;25(10):762-8. doi: 10.1111/j.1365-2362.1995.tb01955.x.

Abstract

This study examines the role of uraemia and the effect of different dialysis treatments on red cell cation transport. We evaluated the main cation transport systems in erythrocytes of non-dialysed end-stage renal disease (ESRD) subjects, of patients undergoing haemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD), as well as the changes induced by human recombinant erythropoietin (r-HuEPO) administration. In uraemic undialysed and dialysed patients, we observed an increase in K/Cl co-transport activity and in shrinkage-induced amiloride-sensitive (HMA-sensitive) Na efflux (Na/H exchange) and a decrease in Na/K pump and Na/K/Cl co-transport activity, while Na/Li exchange was increased only in dialysed patients. In uraemic erythrocytes, we showed for the first time an increased K/Cl co-transport activity, which was cell age independent. Generally, the different method of dialysis (CAPD or HD) did not modify the cation transport abnormalities observed. During the treatment with r-HuEPO, all the systems, with the exception of the Na/K pump and Na/K/Cl co-transport, increased their activities following the increase of circulating young red cells. The changes produced under r-HuEPO administration were transient and cation transports returned to the baseline values within 100 days of treatment, indicating a primary and prominent pathogenetic role of uraemia in modulating the red cell membrane cation transport activities.

摘要

本研究探讨尿毒症的作用以及不同透析治疗对红细胞阳离子转运的影响。我们评估了未透析的终末期肾病(ESRD)患者、接受血液透析(HD)和持续性非卧床腹膜透析(CAPD)的患者红细胞中的主要阳离子转运系统,以及重组人促红细胞生成素(r-HuEPO)给药所引起的变化。在未透析和已透析的尿毒症患者中,我们观察到K/Cl协同转运活性增加,以及收缩诱导的氨氯地平敏感(HMA敏感)钠外流(Na/H交换)增加,而Na/K泵和Na/K/Cl协同转运活性降低,而Na/Li交换仅在已透析患者中增加。在尿毒症红细胞中,我们首次发现K/Cl协同转运活性增加,且与细胞年龄无关。一般来说,不同的透析方法(CAPD或HD)并未改变所观察到的阳离子转运异常。在用r-HuEPO治疗期间,除Na/K泵和Na/K/Cl协同转运外,所有系统随着循环中年轻红细胞数量的增加而增加其活性。r-HuEPO给药后产生的变化是短暂的,阳离子转运在治疗后100天内恢复到基线值,这表明尿毒症在调节红细胞膜阳离子转运活性方面具有主要且突出的致病作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验